IMPALA Consortium
Inter-Company Quality Analytics
IMPALA aims to engage with Health Authorities inspectors on defining guiding principles for the use of advanced analytics to complement, enhance and accelerate current QA practices

The IMPALA ecosystem (industry, regulators, patients) will contribute to a change in paradigm for QA, i.e., where co-developed advanced analytics and best practices can help detect and mitigate issues faster, reduce the burden of retrospective, time-consuming traditional QA activities and ultimately accelerate approval and patient access to innovative drugs
Membership
Make valuable contributions to shift the quality assurance paradigm in the biopharmaceutical industry
Connect with experts across the industry
- Enhance knowledge in areas of interest and expertise through work group projects
- Access to members-only meetings, resources, materials, and work products prior to public publishing
- Where relevant, be included in webinars, presentations, and press releases highlighting the work of the consortium
- Be a part of the movement to accelerate approval and patient access to innovative drugs
Work Products
Publications
Clinical Safety Reporting
Audit Site Selection
Anomaly Detection in Clinical Data
Anomaly Detection in Audit Trial
RQA Workshop with Inspectors
DIA 2023 Workshop
1 Publication
1 Published Work Product
News / Events
IMPALA Webinar: Embedding an Open Source Package into Analytics-Based Audits
Arpana Patel2023-09-20T14:42:17-04:00September 20, 2023|News|
IMPALA Consortium at DIA 2023
Arpana Patel2023-07-19T14:41:22-04:00July 19, 2023|News|
IMPALA Consortium Welcome New Members
Arpana Patel2023-05-16T09:05:28-04:00May 16, 2023|News|
RQA Quality Conversation Session
Arpana Patel2023-05-10T15:51:41-04:00May 10, 2023|News|